Furthermore, APP has been reported to downregulate β-catenin expression by increasing its degradation (32, 33), and overexpressed APP prevents β-catenin translocation into the nucleus through physical binding and precludes the transcription of Wnt target genes in AD disease models (21). Here, APP is linked to Alzheimer disease.